ATE33835T1 - Verbindung mit antibronchopneumopathischer wirkung, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen. - Google Patents
Verbindung mit antibronchopneumopathischer wirkung, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.Info
- Publication number
- ATE33835T1 ATE33835T1 AT85100563T AT85100563T ATE33835T1 AT E33835 T1 ATE33835 T1 AT E33835T1 AT 85100563 T AT85100563 T AT 85100563T AT 85100563 T AT85100563 T AT 85100563T AT E33835 T1 ATE33835 T1 AT E33835T1
- Authority
- AT
- Austria
- Prior art keywords
- compound
- antibronchopneumopathic
- activity
- preparation
- pharmaceutical compositions
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- -1 2-(2-Thenoyl)amino-3,5-dibromophenyl Chemical group 0.000 abstract 1
- OHUOPQPLEZZGON-UHFFFAOYSA-N 4-[(1-amino-3,5-dibromocyclohexa-2,4-dien-1-yl)methylamino]cyclohexan-1-ol Chemical compound C1CC(O)CCC1NCC1(N)CC(Br)=CC(Br)=C1 OHUOPQPLEZZGON-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- QIQITDHWZYEEPA-UHFFFAOYSA-N thiophene-2-carbonyl chloride Chemical compound ClC(=O)C1=CC=CS1 QIQITDHWZYEEPA-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT8419374A IT1213132B (it) | 1984-02-02 | 1984-02-02 | Agente antibroncopneumopatico. |
| EP85100563A EP0150787B1 (de) | 1984-02-02 | 1985-01-20 | Verbindung mit antibronchopneumopathischer Wirkung, Verfahren zur Herstellung und sie enthaltende pharmazeutische Zusammensetzungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE33835T1 true ATE33835T1 (de) | 1988-05-15 |
Family
ID=11157151
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT85100563T ATE33835T1 (de) | 1984-02-02 | 1985-01-20 | Verbindung mit antibronchopneumopathischer wirkung, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen. |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0150787B1 (de) |
| AT (1) | ATE33835T1 (de) |
| DE (2) | DE3562374D1 (de) |
| ES (1) | ES8601181A1 (de) |
| IT (1) | IT1213132B (de) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1248702B (it) * | 1990-06-06 | 1995-01-26 | Yason Srl | Agente antitussivo e mucoregolatore,sua preparazione e composizioni farmaceutiche |
| WO2014037832A2 (en) | 2012-09-06 | 2014-03-13 | Mahesh Kandula | Compositions and methods for the treatment of epilepsy and neurological diseases |
| WO2013167990A1 (en) | 2012-05-07 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of depression |
| SG11201407300VA (en) | 2012-05-07 | 2014-12-30 | Cellix Bio Private Ltd | Compositions and methods for the treatment of neurological disorders |
| EP2847158A4 (de) | 2012-05-07 | 2015-12-30 | Cellix Bio Private Ltd | Zusammensetzungen und verfahren zur behandlung neuromuskulärer erkrankungen und neurodegenerativer erkrankungen |
| US9309233B2 (en) | 2012-05-08 | 2016-04-12 | Cellix Bio Private Limited | Compositions and methods for the treatment of blood clotting disorders |
| US9522884B2 (en) | 2012-05-08 | 2016-12-20 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic disorders |
| WO2013167993A1 (en) | 2012-05-08 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of neurological degenerative disorders |
| WO2013168023A1 (en) | 2012-05-08 | 2013-11-14 | Mahesh Kandula | Compositions and methods for treatment of parkinson's disease |
| WO2013167992A1 (en) | 2012-05-08 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of inflammatory disorders |
| WO2013167997A2 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of metabolic syndrome |
| US9499527B2 (en) | 2012-05-10 | 2016-11-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of familial amyloid polyneuropathy |
| US9242939B2 (en) | 2012-05-10 | 2016-01-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of respiratory disorders |
| WO2013168005A2 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of restless leg syndrome and fibromyalgia |
| US9315461B2 (en) | 2012-05-10 | 2016-04-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurologic diseases |
| US9403857B2 (en) | 2012-05-10 | 2016-08-02 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic syndrome |
| WO2013168000A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of severe pain |
| WO2013168011A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of chronic pain |
| WO2013168033A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for treatment of neurologic diseases |
| WO2013168004A2 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of fibromyalgia pain |
| US9233161B2 (en) | 2012-05-10 | 2016-01-12 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological conditions |
| US9394288B2 (en) | 2012-05-10 | 2016-07-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of asthma and allergy |
| WO2013168001A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of moderate to severe pain |
| CA2873098A1 (en) | 2012-05-23 | 2013-11-28 | Cellixbio Private Limited | Compositions and methods for the treatment of multiple sclerosis |
| SG11201407319YA (en) | 2012-05-23 | 2014-12-30 | Cellix Bio Private Ltd | Compositions and methods for treatment of inflammatory bowel disease |
| WO2013175344A2 (en) | 2012-05-23 | 2013-11-28 | Mahesh Kandula | Compositions and methods for the treatment of periodontitis and rheumatoid arthritis |
| WO2013175376A2 (en) | 2012-05-23 | 2013-11-28 | Mahesh Kandula | Compositions and methods for the treatment of local pain |
| WO2013175347A2 (en) * | 2012-05-23 | 2013-11-28 | Mahesh Kandula | Compositions and methods for the treatment of respiratory disorders |
| SG11201407326XA (en) | 2012-05-23 | 2014-12-30 | Cellix Bio Private Ltd | Compositions and methods for treatment of mucositis |
| US9108942B1 (en) | 2014-11-05 | 2015-08-18 | Mahesh Kandula | Compositions and methods for the treatment of moderate to severe pain |
| WO2014020480A2 (en) | 2012-08-03 | 2014-02-06 | Mahesh Kandula | Compositions and methods for the treatment migraine and neurologic diseases |
| WO2014037833A2 (en) | 2012-09-06 | 2014-03-13 | Mahesh Kandula | Compositions and methods for the treatment inflammation and lipid disorders |
| CA2873029A1 (en) | 2012-09-08 | 2014-03-13 | Cellixbio Private Limited | Compositions and methods for the treatment of inflammation and lipid disorders |
| US9333187B1 (en) | 2013-05-15 | 2016-05-10 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammatory bowel disease |
| SG11201509782TA (en) | 2013-06-04 | 2015-12-30 | Cellix Bio Private Ltd | Compositions and methods for the treatment of diabetes and pre-diabetes |
| US9096537B1 (en) | 2014-12-31 | 2015-08-04 | Mahesh Kandula | Compositions and methods for the treatment of mucositis |
| CA2976314C (en) | 2014-09-26 | 2021-02-23 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy and neurological disorders |
| CA2967908C (en) | 2014-09-29 | 2020-11-17 | Mahesh Kandula | Compositions and methods for the treatment of multiple sclerosis |
| JP6564868B2 (ja) | 2014-10-27 | 2019-08-21 | セリックス バイオ プライヴェート リミテッドＣｅｌｌｉｘ Ｂｉｏ Ｐｒｉｖａｔｅ Ｌｉｍｉｔｅｄ | 多発性硬化症の治療のための、フマル酸モノメチルエステルとピペラジン又はエチレンジアミンとの３つの成分の塩 |
| US9321716B1 (en) | 2014-11-05 | 2016-04-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic syndrome |
| US9150557B1 (en) | 2014-11-05 | 2015-10-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of hyperglycemia |
| US9290486B1 (en) | 2014-11-05 | 2016-03-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy |
| US10208014B2 (en) | 2014-11-05 | 2019-02-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological disorders |
| US9175008B1 (en) | 2014-11-05 | 2015-11-03 | Cellix Bio Private Limited | Prodrugs of anti-platelet agents |
| US9173877B1 (en) | 2014-11-05 | 2015-11-03 | Cellix Bio Private Limited | Compositions and methods for the treatment of local pain |
| US9284287B1 (en) | 2014-11-05 | 2016-03-15 | Cellix Bio Private Limited | Compositions and methods for the suppression of carbonic anhydrase activity |
| US9932294B2 (en) | 2014-12-01 | 2018-04-03 | Cellix Bio Private Limited | Compositions and methods for the treatment of multiple sclerosis |
| US9206111B1 (en) | 2014-12-17 | 2015-12-08 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological diseases |
| CN110845355A (zh) | 2015-01-06 | 2020-02-28 | 塞尔利克斯生物私人有限公司 | 用于治疗炎症和疼痛的组合物和方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1593579B1 (de) * | 1966-05-10 | 1972-02-03 | Thomae Gmbh Dr K | Hydroxy-cyclohexylamine,deren physiologisch vertraeglichen Saeureadditionssalze und Verfahren zu ihrer Herstellung |
-
1984
- 1984-02-02 IT IT8419374A patent/IT1213132B/it active
-
1985
- 1985-01-20 DE DE8585100563T patent/DE3562374D1/de not_active Expired
- 1985-01-20 EP EP85100563A patent/EP0150787B1/de not_active Expired
- 1985-01-20 DE DE198585100563T patent/DE150787T1/de active Pending
- 1985-01-20 AT AT85100563T patent/ATE33835T1/de not_active IP Right Cessation
- 1985-02-01 ES ES540041A patent/ES8601181A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| EP0150787B1 (de) | 1988-04-27 |
| EP0150787A2 (de) | 1985-08-07 |
| ES540041A0 (es) | 1985-11-01 |
| IT8419374A0 (it) | 1984-02-02 |
| EP0150787A3 (en) | 1985-08-21 |
| DE3562374D1 (en) | 1988-06-01 |
| IT1213132B (it) | 1989-12-14 |
| DE150787T1 (de) | 1986-01-02 |
| ES8601181A1 (es) | 1985-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE33835T1 (de) | Verbindung mit antibronchopneumopathischer wirkung, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| EP0368640A3 (de) | Heterozyklische Verbindungen | |
| TW243449B (de) | ||
| HUT45230A (en) | Process for producing new phenoxy-acetic acid derivatives and pharmaceuticals comprising such compounds | |
| AU7124391A (en) | Condensed thiazole compounds, their production and use | |
| NO305515B1 (no) | 5-amino-8-metyl-7-pyrrolidinylkinolin-3-karboksylsyrederivater og farmas°ytiske preparater inneholdende disse | |
| HUT50349A (en) | Process for production of new cefem-compositions | |
| EP0270093A3 (de) | Lactamderivate, Verfahren zu deren Herstellung, sie enthaltende pharmazeutische Zusammensetzungen und ihre Verwendung zur Herstellung von aktiven therapeutischen Arzneimitteln | |
| JPS56122379A (en) | 1-carba-2-penem-3-carboxylic acid derivative | |
| EP0134582A3 (de) | Peptide, Verfahren zur deren Herstellung und pharmazeutische Zusammensetzungen | |
| ES8701143A1 (es) | Un procedimiento para la preparacion de nuevos aminas terciarias. | |
| HU903092D0 (en) | Process for the preparation of buten-carboxylic acid derivatives and pharmaceutical compositions containing such compounds | |
| ZA891769B (en) | Heterocyclic compounds | |
| ATE86117T1 (de) | Zusammensetzung gegen leberkrankheiten. | |
| JPS5673046A (en) | Decaprenylamine derivative | |
| JPS5585550A (en) | 4-homoisotwistane amino acid amide | |
| ATE105476T1 (de) | Dihydropyridin-verbindung zur verbesserung der adernausdehnung und hemmung der herzhypertrophie. | |
| EP0035270A3 (de) | Heterocyclische Verbindungen, ihre Zusammensetzungen, ihre Herstellung und Verwendung | |
| ES8603180A1 (es) | Procedimiento de obtencion de la n-(2-tenoil)-n-(2-ceto-2, 3, 4, 5-tetrahidro-tiofen-3-il)-amina | |
| CS321784A2 (en) | Zpusiob vyroby l,3 bis(dimethylamino) 2 propyl 4 chlor fenoxyacetatu |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |